London payments technology company Form3 has extended its Series C round to 拢46 million.
The fresh investment from British Patient Capital and existing shareholders, including Visa, values the company at around 拢436m.
A cloud-native account-to-account platform founded in 2016, Form3鈥檚 mission is to fundamentally change how technology in banking operates.
The funding will enable the firm to develop new products and services to help support exponential growth in key markets such as the UK, Europe and the US.
In 2021, Form3 raised 拢116m in a funding round led by Goldman Sachs.
鈥淏ritish Patient Capital鈥檚 investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world鈥檚 most established banks and financial institutions,鈥� said CFO Benyam Hagos.
Listed FinTech CEO leaving podium 鈥榬ight decision for company鈥�
Tom Haywood, managing director, direct investments at British Patient Capital, said: 鈥淔orm3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure.聽
鈥淲e are delighted to support them as they take the next steps in their growth journey.鈥�